Loading...
Addition of Muramyl Tripeptide to Chemotherapy for Patients with Newly Diagnosed Metastatic Osteosarcoma: a Report from the Children's Oncology Group
BACKGROUND: The addition of liposomal muramyl tripeptide phosphatidylethanolamine (L-MTPPE) to chemotherapy has been shown to improve overall survival in patients with non-metastatic osteosarcoma (OS). We report the results of L-MTP-PE addition to chemotherapy for patients with metastatic OS. METHOD...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2783515/ https://ncbi.nlm.nih.gov/pubmed/19637348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24566 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|